Drug Interactions between Xofluza and Zofran
This report displays the potential drug interactions for the following 2 drugs:
- Xofluza (baloxavir marboxil)
- Zofran (ondansetron)
Interactions between your drugs
No interactions were found between Xofluza and Zofran. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Xofluza
A total of 53 drugs are known to interact with Xofluza.
- Xofluza is in the drug class miscellaneous antivirals.
- Xofluza is used to treat the following conditions:
Zofran
A total of 358 drugs are known to interact with Zofran.
- Zofran is in the drug class 5HT3 receptor antagonists.
- Zofran is used to treat the following conditions:
Drug and food interactions
baloxavir marboxil food
Applies to: Xofluza (baloxavir marboxil)
GENERALLY AVOID: Coadministration with foods or medications that contain polyvalent cations such as dairy products, calcium-fortified beverages, certain laxatives, antacids, or oral supplements may decrease the plasma concentrations and therapeutic efficacy of baloxavir. The proposed mechanism is chelation of baloxavir by polyvalent cations, forming a complex that is poorly absorbed from the gastrointestinal tract. A significant decrease in baloxavir exposure was observed in monkeys when the prodrug, baloxavir marboxil, was coadministered with calcium, aluminum, magnesium, or iron. However, clinical data in humans are lacking.
When baloxavir marboxil was administered with food, baloxavir peak plasma concentration (Cmax) and systemic exposure (AUC) decreased by 48% and 36%, respectively, relative to administration under fasting. These changes are not considered clinically significant.
MANAGEMENT: Baloxavir marboxil may be taken with or without food. However, coadministration with dairy products, calcium-fortified beverages, or polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc) should be avoided.
References (2)
- Cerner Multum, Inc. "Australian Product Information."
- (2018) "Product Information. Xofluza (baloxavir marboxil)." Genentech
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.